‘IL-2Rα-biased’ IL-2 for cancer immunotherapy
Crossref DOI link: https://doi.org/10.1038/s43018-023-00613-z
Published Online: 2023-08-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Text and Data Mining valid from 2023-08-07
Version of Record valid from 2023-08-07
Article History
First Online: 7 August 2023
